Cited by 1,585Atrial Fibrillation Management and OutcomesCardiac pacing and defibrillation studiesHeart Failure Treatment and Management

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Roy, Denis, Talajic, Mario, Nattel, Stanley, Wyse, D. George, Dorian, Paul, Lee, Kerry L., Bourassa, Martial G., Arnold, J. Malcolm O., Buxton, Alfred E., Camm, A. John, Connolly, Stuart J., Dubuc, Marc, Ducharme, Anique, Guerra, Peter G., Hohnloser, Stefan H., Lambert, Jean, Le Heuzey, Jean-Yves, O'Hara, Gilles, Pedersen, Ole Dyg, Rouleau, Jean-Lucien, Singh, Bramah N., Stevenson, Lynne Warner, Stevenson, William G., Thibault, Bernard, Waldo, Albert L.·2008·New England Journal of Medicine

DOI 10.1056/nejmoa0708789

Open this paper in CoChat — free account

Abstract

BACKGROUND: It is common practice to restore and maintain sinus rhythm in patients with atrial fibrillation and heart failure. This approach is based in part on data indicating that atrial fibrillation is a predictor of death in patients with heart failure and suggesting that the suppression of atrial fibrillation may favorably affect the outcome. However, the benefits and risks of this approach have not been adequately studied. METHODS: We conducted a multicenter, randomized trial comparing the maintenance of sinus rhythm (rhythm control) with control of the ventricular rate (rate control) in patients with a left ventricular ejection fraction of 35% or less, symptoms of congestive heart failure, and a history of atrial fibrillation. The primary outcome was the time to death from cardiovascular causes. RESULTS: A total of 1376 patients were enrolled (682 in the rhythm-control group and 694 in the rate-control group) and were followed for a mean of 37 months. Of these patients, 182 (27%) in the rhythm-control group died from cardiovascular causes, as compared with 175 (25%) in the rate-control group (hazard ratio in the rhythm-control group, 1.06; 95% confidence interval, 0.86 to 1.30; P=0.59 by the log-rank test). Secondary outcomes were similar in the two groups, including death from any cause (32% in the rhythm-control group and 33% in the rate-control group), stroke (3% and 4%, respectively), worsening heart failure (28% and 31%), and the composite of death from cardiovascular causes, stroke, or worsening heart failure (43% and 46%). There were also no significant differences favoring either strategy in any predefined subgroup. CONCLUSIONS: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy. (ClinicalTrials.gov number, NCT00597077.)

Integrity signals

Registry

Crossref · 10.1056/nejmoa0708789

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
A comparison of rate control and rhythm control in patients with atrial fibrillation
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa021328 · Cited by 4,405
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Fuster, V., Rydén, L. E., Cannom, D. S., Crijns, H. J., Curtis, A. B., Ellenbogen, K. A., Halperin, J. L., Le Heuzey, J.-Y., Kay, G. N., Lowe, J. E., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.177292 · Cited by 2,805
Self-citation
A Comparison of Rate Control and Rhythm Control in Patients with Recurrent Persistent Atrial Fibrillation
Gelder, I. C. V., Hagens, V. E., Bosker, H. A., Kingma, J. H., Otto Kamp, B., Kingma, T., Said, S. A., Darmanata, J. I., Timmermans, A. J. M., Tijssen, J. G. P., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021375 · Cited by 2,355
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
Feinberg, W. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.5.469 · Cited by 2,282
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., CHAITMAN, B. R., FROMER, M. A., Gregoratos, G., Klein, G. J., Myerburg, R. J., Quiñones, M. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.010 · Cited by 1,975
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,426

Flagged first, then by citations

Show all 41 references

Research works printed but not linked: 1

Carson PE, 1993, Circulation, 87, VI

Sorted by citations

Items 901–999 of 999

Atrial fibrillation management: evaluating rate vs rhythm control
Nguyen, T. L., Jolly, U. S., Sidhu, K., Yee, R. K., & Leong‐Sit, P. (2016) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2016.1164033 · Cited by 4
Clinical Pearls in Using Antiarrhythmic Drugs in the Outpatient Setting
Parker, M. H., & Sanoski, C. A. (2015) · Journal of Pharmacy Practice · doi:10.1177/1933719115615878 · Cited by 4
Management Of Atrial Fibrillation In Patients With Heart Failure.
Md, A. E. D. (2014) · PubMed Central · doi:10.4022/jafib.1105 · Cited by 4
Vorhofflimmern als Komorbidität bei Herzinsuffizienz
Wachter, R. (2018) · Der Internist · doi:10.1007/s00108-018-0411-8 · Cited by 4
Invasive therapies for patients with concomitant heart failure and atrial fibrillation
Wei, W., Shehata, M. M., Wang, X., Rao, F., Xian-zhan, Z., Guo, H., Fang, X., Liao, H., Liu, J., Deng, H., et al. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09795-0 · Cited by 4
Current Management and Treatment
Altinier, A., Paldino, A., Gigli, M., Pappalardo, A., & Sinagra, G. (2019) · Springer eBooks · doi:10.1007/978-3-030-13864-6_13 · Cited by 4
Impact of successful restoration of sinus rhythm in patients with atrial fibrillation and acute heart failure: Results from the Korean Acute Heart Failure registry
Cho, Y., Oh, I., Park, J. J., Oh, B., Jeon, E., Kim, J., Hwang, K., Cho, M., Chae, S. C., Baek, S. H., et al. (2020) · Cardiology Journal · doi:10.5603/cj.a2020.0103 · Cited by 4
Strategies for Rhythm Control in Atrial Fibrillation
Narayanan, K. (2020) · Indian Journal of Clinical Cardiology · doi:10.1177/2632463620936018 · Cited by 4
Atrial Fibrillation and Heart Failure
Marzlin, K. M. (2020) · AACN Advanced Critical Care · doi:10.4037/aacnacc2020202 · Cited by 4
Implantation of a cardiac contractility modulator in chronic heart failure and atrial fibrillation: results of a 6-month follow-up of one hundred patients
Uskach, T. M., Валерьевич, С. О., Safiullina, A. A., Grishin, I. Y., Amanatova, V. A., Akchurin, R. S., & Tereshchenko, S. N. (2021) · Russian Journal of Transplantology and Artificial Organs · doi:10.15825/1995-1191-2021-1-30-37 · Cited by 4
The role of atrial fibrillation catheter ablation in patients with heart failure
Bernard, M. L., Benn, F. A., Williams, C. M., Hiltbold, A. E., Rogers, P. A., Polin, G. M., Khatib, S., Al‐Khatib, S. M., & Morin, D. P. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.06.002 · Cited by 4
Mechanism and prevention strategy of a bidirectional relationship between heart failure and cancer (Review)
Cai, H., Men, H., Cao, P., & Zheng, Y. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10898 · Cited by 4
Atrial fibrillation ablation in heart failure patients: Where do we stand in 2023? – State of the art review
Deering, T. F., Goyal, S., Bhimani, A. A., Hoosien, M., Karimianpour, A., Krishnasamy, K. P., Nilsson, K. R., Omar, A., Lakkireddy, D., Gopinathannair, R., et al. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14888 · Cited by 4
A Q-transform-based deep learning model for the classification of atrial fibrillation types
Dhananjay, B., Kumar, R. P., Neelapu, B. C., Pal, K., & Sivaraman, J. (2024) · Physical and Engineering Sciences in Medicine · doi:10.1007/s13246-024-01391-3 · Cited by 4
Clinical decisions for appropriate management of patients with atrial fibrillation
Boriani, G., Bonini, N., Imberti, J. F., Vitolo, M., Gerra, L., Mantovani, M., Serafini, K., Birtolo, C., Tartaglia, E., & Mei, D. A. (2024) · Panminerva Medica · doi:10.23736/s0031-0808.24.05114-0 · Cited by 4
Association between clinical outcome and antiarrhythmic treatment in heart failure patients who have atrial fibrillation upon admission to the hospital
Watanabe, E., Arakawa, T., Okuda, K., Yamamoto, M., Ichikawa, T., Harigaya, H., Sobue, Y., & Ozaki, Y. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.01.022 · Cited by 4
Cardiac Dysrhythmias
Methangkool, E., Howard-Quijano, K. J., & Mahajan, A. (2018) · Advances in Anesthesia · doi:10.1016/j.aan.2018.07.008 · Cited by 4
Determinants of sinus rhythm maintenance in patients with early-persistent atrial fibrillation and heart failure
for the RACE 3 investigators, With, R. R. D., Rienstra, M., Crijns, H. J. G. M., & Gelder, I. C. V. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01581-0 · Cited by 4
CARDIOPATÍA EN EL PACIENTE ANCIANO
Sonia Kunstmann, F., & Gainza, I. F. (2020) · Revista Médica Clínica Las Condes · doi:10.1016/j.rmclc.2019.11.010 · Cited by 4
An updated systematic review on heart failure treatments for patients with renal impairment: the tide is not turning
Hey, C. Y., Barra, S., Duehmke, R. M., Pettit, S., Levy, W. C., Silva‐Cardoso, J., & Providencia, R. A. (2022) · Heart Failure Reviews · doi:10.1007/s10741-022-10216-y · Cited by 4
Effect of concomitant surgical atrial fibrillation ablation in patients with reduced left ventricle ejection fraction: A propensity‐score matching analysis
Rimac, G., Lauzon, N., Sénéchal, M., Dagenais, F., Jacques, F., Philippon, F., & Voisine, P. (2022) · Journal of Cardiac Surgery · doi:10.1111/jocs.16927 · Cited by 4
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil
Krishnamoorthy, S., & Lip, G. Y. H. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903114150 · Cited by 4
New Evidence, New Controversies: a Critical Review of the European Society of Cardiology 2010 Clinical Practice Guidelines on Atrial Fibrillation
Anguita, M. P., Worner, F., Domenech, P., Marín, F. R., Ortigosa, J., Pérez‐Villacastín, J., Fernández‐Ortíz, A., Alonso, Á., Cequier, A. R., Colet, J. C., et al. (2011) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2011.10.005 · Cited by 4
Non-investigational antiarrhythmic drugs: long-term use and limitations
Gjesdal, K. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330902927647 · Cited by 4
Current atrial fibrillation guidelines and therapy algorithms: Are they adequate?
Lévy, S. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9320-4 · Cited by 4
Acute effects of adrenergic agents on post-defibrillation arrest time in a cultured heart model
Krauthamer, V., & Smith, T. C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4372-9 · Cited by 4
Outcomes after stepwise ablation for persistent atrial fibrillation in patients with heart failure
Takahashi, Y., Takahashi, A., Kuwahara, T., Okubo, K., Takagi, K., Watari, Y., Takigawa, M., Nakashima, E., Kawaguchi, N., Yamao, K., et al. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.05.010 · Cited by 4
Antiarrhythmic Drugs in Atrial Fibrillation: Do They Have a Future?
Angaran, P., & Dorian, P. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.04.033 · Cited by 4
Rethinking the reasons to treat atrial fibrillation? The role of dronedarone in reducing cardiovascular hospitalizations
Falk, R. H., & Camm, A. J. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp381 · Cited by 4
Atrial Fibrillation in Congestive Heart Failure: Current Management
Boyle, N. G., & Shivkumar, K. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.09.016 · Cited by 4
Atrial fibrillation: Pathophysiology and current therapy
Miyazaki, S., Shah, A. J., Scherr, D., & Haı̈ssaguerre, M. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.554426 · Cited by 4
Atrial Fibrillation (AF) and Heart Failure (HF): To Treat the AF, be Sure to Treat the HF
Prudente, L. A. (2008) · Progress in Cardiovascular Nursing · doi:10.1111/j.1751-7117.2008.00007.x · Cited by 4
Bucindolol hydrochloride in atrial fibrillation and concomitant heart failure
Black‐Maier, E., Steinberg, B. A., & Piccini, J. P. (2015) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2015.1031111 · Cited by 4
Management of atrial fibrillation in patients with heart failure: from drug therapy to ablation
Wongcharoen, W., & Chen, S. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.311 · Cited by 4
Short-term amiodarone therapy after reversion of persistent atrial fibrillation reduces recurrences at 18 months
Galperín, J., Elizari, M. V., Bonato, R., Ledesma, R., Blanco, M. V., Lago, M., Spada, P., Sanchez, J., Piasentin, J. A., & Chiale, P. A. (2013) · Cardiology Journal · doi:10.5603/cj.a2013.0152 · Cited by 4
Rate Versus Rhythm Control for Atrial Fibrillation
Halsey, C., & Chugh, A. (2016) · Heart Failure Clinics · doi:10.1016/j.hfc.2015.08.016 · Cited by 4
Neurologic complications of cardiomyopathies and other myocardial disorders
Moran, J. F. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4086-3.00009-6 · Cited by 4
Arrhythmias and cardiomyopathy
Bonadei, I., Gorga, E., Lombardi, C., & Metra, M. (2016) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000464 · Cited by 4
Ablation of Atrial Fibrillation in Combination with Left Atrial Appendage Occlusion in A Single Procedure. Rationale and Technique.
Bolao, I. G., Calvo, N., Macı́as, A., Barba, J., Salterain, N., Ramos, P., Ballesteros, G., & Neglia, R. (2016) · PubMed Central · doi:10.4022/jafib.1346 · Cited by 4
Cardiac fibrillation—challenges and evolving solutions
Nattel, S. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.133 · Cited by 4
NHG-Standaard Atriumfibrilleren
Boode, B. S. P., Heeringa, J., Konings, K., Rutten, F., den Berg, P. V., Zwietering, P. J., van Lieshout, J., & Opstelten, W. (2011) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8279-8_18 · Cited by 4
Atrial fibrillation
Khoo, C. W., Krishnamoorthy, S., & Lip, G. Y. H. (2010) · Medicine · doi:10.1016/j.mpmed.2010.06.009 · Cited by 4
The risk of antiarrhythmic drugs in atrial fibrillation: 20 years of controversies
Heuzey, J. Y. L. (2009) · EP Europace · doi:10.1093/europace/eup175 · Cited by 4
New Oral Anticoagulants in Atrial Fibrillation Forever?
Verheugt, F. W. A. (2013) · Circulation · doi:10.1161/circulationaha.113.003825 · Cited by 4
Mineralocorticoid Receptor Antagonists and Mortality in Heart Failure With Concurrent Atrial Fibrillation
McCullough, P. A., & Cowan, S. (2012) · Circulation Heart Failure · doi:10.1161/circheartfailure.112.970384 · Cited by 4
Acute Rate Control in Atrial Fibrillation With Left Ventricular Dysfunction
Momomura, S. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0289 · Cited by 4
Atrial Fibrillation in Heart Failure
Koplan, B. A., & Stevenson, W. G. (2016) · Circulation · doi:10.1161/circulationaha.116.022261 · Cited by 4
Atrial Fibrillation, an Under-Appreciated Reversible Cause of Cardiomyopathy: Implications for Clinical Practice From the CAMERA-MRI Study
Prabhu, S., & Kistler, P. M. (2018) · Heart Lung and Circulation · doi:10.1016/s1443-9506(18)30152-5 · Cited by 4
Potential use of ivabradine for treatment of atrial fibrillation
Koenig, S. N., & Mohler, P. J. (2018) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.13788 · Cited by 4
From bench to bedside: The clinical relevance of atrial electrical remodeling in atrial fibrillation therapy
Frontera, A., Latini, A. C., Krisai, P., Battaglia, V., Gottlieb, L. A., Vlachos, K. G., Gigli, L., Guarracini, F., Baroni, M., Preda, A., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2025.12.041 · Cited by 3
Catheter Ablation of atrial fibrillation vs. atrioventricular nodal ablation with Conduction system pacing in persistent atrial fibrillation and heart failure (ABACUS): rationale and design
Burri, H., Kozhuharov, N., Bode, K., Cano, Ó., Čurila, K., Drossart, I., Geller, L. A., Heidbüchel, H., Jastrzębski, M., Karvonen, J., et al. (2026) · European Heart Journal Open · doi:10.1093/ehjopen/oeag007 · Cited by 4
Management Strategies in Atrial Fibrillation in Patients With Heart Failure
Shaikh, A. Y., Maan, A., Heist, E. K., Tighe, D. A., Aurigemma, G. P., & McManus, D. D. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31825dcf9b · Cited by 3
Vernakalant hydrochloride in the treatment of atrial fibrillation: a review of the latest clinical evidence
Marinelli, A., Ciccarelli, I., & Capucci, A. (2011) · Clinical Investigation · doi:10.4155/cli.11.27 · Cited by 3
Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry
Hou, X., He, L., Du, X., Wang, G., Dong, J., & Ma, C. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001270 · Cited by 3
Peculiarities of pharmacotherapy of chronic heart failure with retained left ventricular efficiency and associated atrial fibrilation depending on the method of heart rhythm control
Zolotarova, T., Bilchenko, O. V., Volkov, D., Pasyura, I., & Prylutska, K. (2022) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2022-44-07 · Cited by 4
Resting heart rate and cardiovascular outcomes in patients with non-paroxysmal atrial fibrillation: CODE-AF registry
Park, H., Yu, H. T., Kim, T., Park, J., Park, J., Kang, K., Uhm, J., Kim, J., Kim, J., Choi, E., et al. (2023) · International Journal of Arrhythmia · doi:10.1186/s42444-023-00090-6 · Cited by 3
Management of Tachycardia-Mediated Cardiomyopathy: Experience from the Vancouver General Hospital Cardiac Function Clinic (TMC-EXPLOR Study)
Daulat, A., MacGillivray, J., Sidsworth, M., & Turgeon, R. D. (2023) · The Canadian Journal of Hospital Pharmacy · doi:10.4212/cjhp.3368 · Cited by 3
Ablation or drug therapy for initial atrial fibrillation
Andrade, J. G. (2024) · Annals of Cardiothoracic Surgery · doi:10.21037/acs-2023-afm-0159 · Cited by 3
Atrial Fibrillation Ablation During Hospitalization for Acute Heart Failure: Feasibility and Role of Pulsed Field Ablation
Marek, J. J., Stojadinovic, P., Wichterle, D., Peichl, P., Hašková, J., Borisincova, E., Stiavnicky, P., Cihak, R. J., Šramko, M., & Kautzner, J. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16507 · Cited by 3
Ablation of Atrial Arrhythmias in Heart Failure
Aagaard, P., Biase, L. D., & Natale, A. (2015) · Heart Failure Clinics · doi:10.1016/j.hfc.2014.12.008 · Cited by 3
The Role of Ablation of the Atrioventricular Junction in Patients with Heart Failure and Atrial Fibrillation
Végh, É., Sood, N. A., & Singh, J. P. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.003 · Cited by 3
Profile of CZECH AF 2012. Profile of atrial fibrillation patients receiving antithrombotic therapy
Špinar, J., Vítovec, J., Špinarová, L., & Musil, V. (2014) · Cor et Vasa · doi:10.1016/j.crvasa.2014.04.001 · Cited by 3
Stroke Prevention in Atrial Fibrillation in Heart Failure
Shantsila, E., & Lip, G. Y. H. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.008 · Cited by 3
2018 Korean Heart Rhythm Society Guidelines for Antiarrhythmic Drug Therapy in Non-valvular Atrial Fibrillation
Kang, K., Shim, J., Ahn, J., Lee, D. I., Kim, J., Joung, B., & Choi, K. (2018) · Korean Journal of Medicine · doi:10.3904/kjm.2018.93.2.140 · Cited by 3
Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
Fedorova, M. H., Doshchitsin, V. L., & Чапурных, А. В. (2018) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2018-14-5-670-677 · Cited by 3
Characteristics and Treatment of Atrial Fibrillation with Respect to the Presence or Absence of Heart Failure. Insights from the Multicenter Polish Atrial Fibrillation (POL-AF) Registry
Gawalko, M. M., Budnik, M., Gorczyca−Michta, I., Jelonek, O. E., Uziębło‐Życzkowska, B., Maciorowska, M., Wójcik, M., Błaszczyk, R. T., Tokarek, T., Rajtar-Salwa, R., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071341 · Cited by 3
Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Khanra, D., Deshpande, S. A., Mukherjee, A., Mohan, S., Khan, H., Kathuria, S., Kella, D., & Padmanabhan, D. (2021) · International Journal of Heart Failure · doi:10.36628/ijhf.2021.0008 · Cited by 3
Atrial Fibrillation Ablation in Heart Failure Patients
Derndorfer, M., Chen, S., & Pürerfellner, H. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163512 · Cited by 3
Treatment strategies for patients with atrial fibrillation and chronic heart failure
Tereshchenko, S. N., & Uskach, T. M. (2021) · Terapevticheskii arkhiv · doi:10.26442/00403660.2021.12.201205 · Cited by 3
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
Girod, M., Coslovsky, M., Aeschbacher, S., Sticherling, C., Reichlin, T., Roten, L., Rodondi, N., Ammann, P., Auricchio, A., Moschovitis, G., et al. (2022) · Clinical Research in Cardiology · doi:10.1007/s00392-022-02015-0 · Cited by 3
Vorhofflimmern
Schnabel, R. B., Rillig, A., & Kirchhof, P. F. (2021) · Der Internist · doi:10.1007/s00108-021-01067-0 · Cited by 3
Target heart rate in heart failure with reduced ejection fraction and atrial fibrillation: Goldilocks zone
Hesse, K. (2022) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2022.100218 · Cited by 3
ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
Skirdenko, Y. P., Валентинович, Ш. А., Валерьевич, Ж. В., & Николаев, Н. А. (2016) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2016-12-2-196-203 · Cited by 3
Management of Atrial Fibrillation in Patients with Heart Failure: Time to Implement Ablation Control
Baher, A. A., & Marrouche, N. F. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1093-0 · Cited by 3
A Compelling Case for Less Aggressive Arrhythmia Management in Patients With Chronic Heart Failure and Long-Standing Atrial Fibrillation
Packer, M. (2019) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2019.08.011 · Cited by 3
Prognostic Significance of Heart Rate and Beta-Blocker Use in Sinus Rhythm in Patients with Heart Failure and Preserved Ejection Fraction
Li, S., & Li, X. (2019) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-019-00341-5 · Cited by 3
Mutual relationship between heart failure and atrial fibrillation
Sarullo, F. M., Schembri, G., Nugara, C., Sarullo, S., Vitale, G., & Corrao, S. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1264 · Cited by 8
Impact of catheter ablation for atrial fibrillation in patients with heart failure and left ventricular systolic dysfunction
Ribeiro, J. M., Sousa, P. A., António, N., Baptista, R., Elvas, L., Barra, S., & Gonçalves, L. M. M. (2021) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repce.2021.07.008 · Cited by 3
Rhythm control versus rate control in patients with atrial fibrillation and heart failure across the left ventricular ejection fraction spectrum
Moysidis, D. V., Κάρτας, Α., Samaras, A., Papazoglou, Α. S., Akrivos, E., Vouloagkas, I., Papanastasiou, A., Vrana, E., Baroutidou, A., Botis, M., et al. (2022) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2022.03.002 · Cited by 3
Frequenz- und Rhythmuskontrolle bei Vorhofflimmern
Weipert, K. F., Erkapic, D., & Schmitt, J. (2015) · Herz · doi:10.1007/s00059-014-4201-3 · Cited by 3
FLECAINIDE TOXICITY IN AN OLDER ADULT
Psaty, B. M., & Psaty, S. E. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2009.02192.x · Cited by 3
Atrial fibrillation in patients with heart failure: Role of catheter ablation therapies.
Shariff, N., Aleem, A., Levin, V., Singh, M., Islam, N., & Freudenberger, R. S. (2012) · Europe PMC (PubMed Central) · Cited by 3
Register und Studien des Deutschen Kompetenznetzes Vorhofflimmern (AFNET)
Näbauer, M., Gerth, A., Kirchhof, P. F., Goette, A., Limbourg, T., Sprenger, C., Hoffmann, B. A., Willems, S., Doll, N., Schuchert, A., et al. (2010) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-010-0097-7 · Cited by 3
[Atrial fibrillation and heart failure].
Capucci, A., & Matassini, M. V. (2010) · PubMed · Cited by 3
Aggressive approach and outcome in patients presenting atrial fibrillation and hypertension
Conti, A., Canuti, E., Mariannini, Y., Zanobetti, M., Innocenti, F., Paladini, B., Pepe, G., Padeletti, L., & Gensini, G. F. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.09.074 · Cited by 3
Does catheter ablation for atrial fibrillation increase or reduce neurological insult?
Healey, J. S., & Nair, G. M. (2011) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32834d846a · Cited by 3
Impact of Atrial Fibrillation on Outcomes in Heart Failure
DePasquale, E. C., & Fonarow, G. C. (2013) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.07.009 · Cited by 3
Comparison of Circumferential Pulmonary Vein Isolation and Antiarrhythmic Drug Therapy in Patients with Atrial Fibrillation
Xu, Y., Sharma, D., Du, F., Li, G., & Xu, G. (2012) · Cardiology and Therapy · doi:10.1007/s40119-012-0003-y · Cited by 3
Do the benefits of anti-arrhythmic drugs outweigh the associated risks? A tale of treatment goals in atrial fibrillation
Kim, M. H. (2012) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.12.5 · Cited by 3
What an emergency physician needs to know about acute care of cardiac arrhythmias
Stellbrink, C. (2010) · Journal of Emergencies Trauma and Shock · doi:10.4103/0974-2700.62109 · Cited by 3
Rate control in atrial fibrillation, insight into the RACE II study
Groenveld, H. F., Crijns, H. J. G. M., Tijssen, J. G. P., Alings, M., Hillege, H. L., Tuininga, Y. S., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2013) · Netherlands Heart Journal · doi:10.1007/s12471-013-0391-1 · Cited by 3
Managing Patients with Rapid Atrial Fibrillation and Decompensated Heart Failure
AlHabeeb, W., & Al‐Admawi, M. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.108.819540 · Cited by 3
Congestive heart failure with and without atrial fibrillation – different patient populations?
Waldenhjort, D., Mejhert, M., Edner, M., Rosenqvist, M., & Persson, H. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430802535048 · Cited by 3
Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation
Lakdawalla, D. N., Turakhia, M. P., Jhaveri, M., Mozaffari, E., Davis, P., Bradley, L. A., & Solomon, M. D. (2013) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.13.19 · Cited by 3
Atrial assistance device, a new alternative to lifelong anticoagulation?
Abdelnour‐Berchtold, E. (2009) · Swiss Medical Weekly · doi:10.4414/smw.2009.12531 · Cited by 3
Rate Control in Atrial Fibrillation: Methods for Assessment, Targets for Ventricular Rate during AF, and Clinical Relevance for Device Therapy.
Sarkar, S., & Ziegler, P. (2013) · Europe PMC (PubMed Central) · doi:10.4022/jafib.791 · Cited by 3
Atrial Fibrillation (Updating the 2006 Guideline) 2011 ACCF/AHA/HRS Focused Update on the Management of Patients With
Tracy, C. M., Ezekowitz, M. D., Slotwiner, D. J., Jackman, W. M., Ellenbogen, A. L., Lowe, J. E., Page, R. L., Wann, L. S., Curtis, A. B., & January, C. T. (2011) · Cited by 3
Atrial fibrillation ablation and left appendage closure in heart failure patients
Patel, M. R., & BIVIANO, A. B. (2015) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000168 · Cited by 3
Autologous Dermal Fibroblast Injections Slow Atrioventricular Conduction and Ventricular Rate in Atrial Fibrillation in Swine
Tondato, F. J., Zeng, H., Goodchild, T. T., Ng, F. S., Chronos, N. A. F., & Peters, N. S. (2015) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.114.001536 · Cited by 3

Authors: Roy, D., Talajic, M., Nattel, S., Wyse, D. G., Dorian, P., Lee, K. L., Bourassa, M. G., Arnold, J. M. O., Buxton, A. E., Camm, A. J., Connolly, S. J., Dubuc, M., Ducharme, A., Guerra, P. G., Hohnloser, S. H., Lambert, J., Le Heuzey, J.-Y., O'Hara, G., Pedersen, O. D., Rouleau, J.-L., Singh, B. N., Stevenson, L. W., Stevenson, W. G., Thibault, B., & Waldo, A. L.
Affiliations: Montreal Heart Institute (CA)
Libin Cardiovascular Institute of Alberta (CA)
St. Michael's Hospital (CA)
Duke Medical Center (US)
London Health Sciences Centre (CA)
Rhode Island Hospital (US)
St George's Hospital (GB)
Population Health Research Institute (CA)
Goethe University Frankfurt (DE)
Bispebjerg Hospital (DK)
VA West Los Angeles Medical Center (US)
Brigham and Women's Hospital (US)
University Hospitals Cleveland Medical Center (US)
ORCID: Roy, Denis
Talajic, Mario
Nattel, Stanley
Dorian, Paul
Bourassa, Martial G.
Buxton, Alfred E.
Camm, A. John
Connolly, Stuart J.
Ducharme, Anique
Guerra, Peter G.
Hohnloser, Stefan H.
Lambert, Jean
Pedersen, Ole Dyg
Rouleau, Jean-Lucien
Stevenson, Lynne Warner
Stevenson, William G.
Thibault, Bernard
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2008-06-19
Volume: 358
Issue: 25
Pages: 2667-2677
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmoa0708789
OpenAlex: W2131260805
Cited by: 1,585
References: 41
Citations by year: 2026: 42 · 2025: 33 · 2024: 69 · 2023: 55 · 2022: 76 · 2021: 86 · 2020: 77 · 2019: 82 · 2018: 96 · 2017: 87 · 2016: 73 · 2015: 75 · 2014: 87 · 2013: 123 · 2012: 114
FWCI: 97.76
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords: atrial fibrillation, heart failure, rhythm control, rate control, sinus rhythm maintenance, ventricular rate control, cardiovascular mortality, congestive heart failure, stroke, worsening heart failure, left ventricular ejection fraction
MeSH terms: Adrenergic beta-Antagonists, Aged, Amiodarone, Angiotensin-Converting Enzyme Inhibitors, Anti-Arrhythmia Agents, Atrial Fibrillation, Cardiovascular Diseases, Combined Modality Therapy, Digitalis Glycosides, Electric Countershock, Female, Follow-Up Studies, Heart Failure, Heart Rate, Hospitalization, Humans, Male, Middle Aged, Prospective Studies, Ventricular Dysfunction, Left, Kaplan-Meier Estimate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rhythm Control versus Rate Control for Atrial Fibrillation and Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks